Advertisement

 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Oncology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links

advertisement.gif (61x7 -- 0 bytes)

   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 

 

 

Back to index

Cancer Chemotherapy Regimen for Carcinoid Cancer


 AP                                                  carcinoid(36)
 _________________________________________________________________
  adriamycin...... 50 mg/sqm IV day 1.
  cisplatin....... 50 mg/sqm IV day 1 with hydration.
  FREQUENCY....... Repeat cycle every 3 or 4 weeks.

  reference...
    Sridhar KS.  Holland JF.  Brown JC.  Cohen JM.  Ohnuma T. 
    Doxorubicin plus cisplatin in the treatment of apudomas. 
    Cancer.  55(11):2634-7, 1985 Jun 1. 
  abstract...
    Twelve patients with advanced apudomas--six with carcinoid 
    tumors, two with chemodectomas, two with pancreatic islet cell 
    tumor, and one each of medullary carcinoma of the thyroid and 
    paraganglioma of unknown primary--were treated with a 
    combination of doxorubicin 50 mg/m2 and cisplatin 50 mg/m2 
    every 3 to 4 weeks. Biochemical markers were present in 8 of 
    the 12 patients. Five of the 12 patients (3 with carcinoid and 
    2 with chemodectomas) responded with more than 50% regression 
    of tumor size measured as hypothetical area. Three others (two 
    with islet cell tumors and one with carcinoid) had clinical 
    and/or biochemical improvements. A median duration of response 
    was 6 months. Nausea, vomiting, and alopecia were universal. 
    Mild or moderate leukopenia was the most frequent toxicity. No 
    sustained nephrotoxicity was seen. The combination of 
    doxorubicin and cisplatin provides a new palliative therapy 
    for patients with APUD tumors. 
 
advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


 

 advertisement.gif (61x7 -- 0 bytes)

 

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2007 The Doctors Lounge. All rights reserved.